Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel approaches and current challenges with targeting the endocannabinoid system
Paula Morales, Nadine Jagerovic
Expert Opinion on Drug Discovery (2020) Vol. 15, Iss. 8, pp. 917-930
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
Ana Lago-Fernandez, Sara Zarzo-Arias, Nadine Jagerovic, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1001-1001
Open Access | Times Cited: 37
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
Jakub Jakowiecki, Renata Abel, Urszula Orzeł, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2456-2456
Open Access | Times Cited: 30
Lipid-based formulations to increase cannabidiol bioavailability: In vitro digestion tests, pre-clinical assessment and clinical trial
Manuel A.A. De Prá, Renata Vardanega, Carla Giane Loss
International Journal of Pharmaceutics (2021) Vol. 609, pp. 121159-121159
Closed Access | Times Cited: 30
Efficacy and safety of cannabidivarin treatment of epilepsy in girls with Rett syndrome: A phase 1 clinical trial
Ellen Hurley, Carolyn Ellaway, Alexandra Johnson, et al.
Epilepsia (2022) Vol. 63, Iss. 7, pp. 1736-1747
Open Access | Times Cited: 21
Cannabis as a Source of Approved Drugs: A New Look at an Old Problem
Adi Gabarin, Ludmila Yarmolinsky, Arie Budovsky, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7686-7686
Open Access | Times Cited: 12
The endocannabinoid system and related lipids as potential targets for the treatment of migraine‐related pain
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, et al.
Headache The Journal of Head and Face Pain (2022) Vol. 62, Iss. 3, pp. 227-240
Closed Access | Times Cited: 18
Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
Jackson M. J. Oultram, Joseph L. Pegler, Tim Bowser, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 234-234
Open Access | Times Cited: 22
Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation
Jiayi Yuan, Bo Ram Yang, Guanyu Hou, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103615-103615
Open Access | Times Cited: 8
Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers
José‐Francisco Rocha, A. Santos, Helena Gama, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 111, Iss. 2, pp. 391-403
Open Access | Times Cited: 19
Small molecules to perform big roles: The search for Parkinson's and Huntington's disease therapeutics
Rodrigo Pérez-Arancibia, Marisol Cisternas-Olmedo, Denisse Sepúlveda, et al.
Frontiers in Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Human epithelial stem cell survival within their niche requires “tonic” cannabinoid receptor 1‐signalling—Lessons from the hair follicle
Koji Sugawara, Nóra Zákány, Stephan Tiede, et al.
Experimental Dermatology (2021) Vol. 30, Iss. 4, pp. 479-493
Open Access | Times Cited: 16
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes
Filippo Basagni, Michela Rosini, Michael Decker
ChemMedChem (2020) Vol. 15, Iss. 15, pp. 1374-1389
Open Access | Times Cited: 16
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis
Chiara Arena, Francesca Gado, Lorenzo Di Cesare Mannelli, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112858-112858
Open Access | Times Cited: 16
Pharmacology of Cannabis
Luxman Srikantha, Nathan Gonik
Springer eBooks (2023), pp. 251-261
Closed Access | Times Cited: 5
Co-delivery of Paclitaxel and Cannabidiol in Lipid Nanoparticles Enhances Cytotoxicity Against Melanoma Cells
Fabíola Vieira de Carvalho, Gabriela Gerônimo, Ludmilla David de Moura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy
Janani Parameswaran, Leire Goicoechea, Laura Planas‐Serra, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 2, pp. 241-258
Closed Access | Times Cited: 7
Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models
Paula Morales, Patricia H. Reggio
Advances in experimental medicine and biology (2020), pp. 47-65
Closed Access | Times Cited: 10
Effect of Fatty Acid Amide Hydrolase Inhibitor URB597 on Orofacial Pain Perception in Rats
Marek Zubrzycki, Maria Zubrzycka, Grzegorz Wysiadecki, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4665-4665
Open Access | Times Cited: 5
Fatty acid amide hydrolase inhibition and N‐arachidonoylethanolamine modulation by isoflavonoids: A novel target for upcoming antidepressants
Wahid Zada, Jonathan W. VanRyzin, Miguel Perez‐Pouchoulen, et al.
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 5
Targeting Endocannabinoid Metabolism: an Arrow with Multiple Tips Against Multiple Sclerosis
Samuele Maramai, Margherita Brindisi
ChemMedChem (2020) Vol. 15, Iss. 21, pp. 1985-2003
Closed Access | Times Cited: 7
Structural Insights into β-arrestin/CB1 Receptor Interaction: NMR and CD Studies on Model Peptides
Paula Morales, Marta Bruix, M. Ángeles Jiménez
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 21, pp. 8111-8111
Open Access | Times Cited: 6
Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569
AyoOluwa O. Aderibigbe, Pankaj Pandey, Robert J. Doerksen
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 13, pp. 5729-5747
Open Access | Times Cited: 6
Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
Özge Boyacıoğlu, Petek Korkusuz
Advances in experimental medicine and biology (2022), pp. 145-169
Closed Access | Times Cited: 4
Agathadiol, a labdane diterpenoid from juniper berries, is a positive allosteric modulator of CB1R
Stefano Salamone, Giovanni Appendino, Adil Khalili, et al.
Fitoterapia (2021) Vol. 155, pp. 105059-105059
Closed Access | Times Cited: 4
Levantamento do uso terapêutico do canabidiol por veterinários na região metropolitana de Belém do Pará
ANA ÍVINA DE CARVALHO COSTA, Aryane Silva, Helamã Tavares, et al.
PubVet (2024) Vol. 18, Iss. 04, pp. e1582-e1582
Open Access
Page 1 - Next Page

Scroll to top